glp-1 next generation What's Coming for and Metabolic Disease Treatment Eli Lilly to seek approval

doi: 10.1080/17446651.2022.2079495 16 KilickapMKozlucaVTanTSAkbulut KoyuncuIM

Post-GLP-1, without its calming effect, cortisol can spike hungerleading to cravings for carbs or sweets

The Future The proven health benefits of GLP-1 receptor agonists (GLPRAs), like liraglutide (Saxenda) and semaglutide (Wegovy), have transformed the treatment of metabolic disease and its discovery has stimulated development of other GLP-1(7-37)-based therapeutic approaches, including an oral GLPRA, which has shown efficacy (1)

Michael Snyder, medical director of the Bariatric Surgery Center at Rose Medical Center and obesity specialist at FuturHealth

Skipping Meals Entirely It can be tempting to skip meals when hunger is low, but doing so regularly may worsen fatigue, dizziness, and nutrient deficiencies